Clinical Trial Applications - Approved: Filter, Search, and view applications


Clear
Extended search...

Page 39 of 59, showing 10 Applications out of 584 total, starting on record 381, ending on 390

# Protocol No Study Title Investigator(s) & Site(s) Date Approved

381.

ECCT/22/10/05   Agios Study
    A Phase 2/3, Double-Blind, Randomized, Placebo-Controlled, Multicenter Study to Evaluate the Efficacy and Safety of Mitapivat in Subjects With Sickle Cell Disease. Mitapivat - AG348-C-020   
Principal Investigator(s)
1. Videlis N Nduba
Site(s) in Kenya
1. KEMRI/CRDR (Nairobi City county)
2. KEMRI Siaya Clinical Research Annex (Siaya county)
 
26-02-2023 View

382.

ECCT/25/06/01   Neosep1
    An open-label randomised controlled trial comparing novel combination and currently used antibiotic regimens for the empiric treatment of neonatal sepsis with a run-in confirmatory pharmacokinetic phase.   
Principal Investigator(s)
1. Christine Nafula Manyasi
Site(s) in Kenya
1. Mbagathi County Referral Hospital (Nairobi City county)
 
02-10-2025 View

383.

ECCT/25/06/02   Neosep1
    An open-label randomised controlled trial comparing novel combination and currently used antibiotic regimens for the empiric treatment of neonatal sepsis with a run-in confirmatory pharmacokinetic phase.   
Principal Investigator(s)
1. Nayirat Mohamed Dormohamed
Site(s) in Kenya
1. Coast General Teaching and Referral Hospital (Mombasa county)
 
02-10-2025 View

384.

ECCT/25/04/03   PRETERM AFRICA STUDY
    Pragmatic Evaluation of Therapies to Enhance Respiratory Management in Preterm Infants in Africa   
Principal Investigator(s)
1. Nayirat Mohamed
Site(s) in Kenya
1. Coast General Teaching and Referral Hospital (Mombasa county)
 
10-03-2026 View

385.

ECCT/25/04/02   PRETERM AFRICA STUDY
    Pragmatic Evaluation of Therapies to Enhance Respiratory Management in Preterm Infants in Africa   
Principal Investigator(s)
1. Justus Simba
Site(s) in Kenya
1. Mama Lucy Kibaki Hospital (Nairobi City county)
 
10-03-2026 View

386.

ECCT/25/02/11   Extended Dosing OCV Trial
    A Phase IV Parallel-Group, Open-Label, Randomized Non-Inferiority Trial Evaluating Immunogenicity of Extended Dosing Intervals for Euvichol-S Oral Cholera Vaccine, Nairobi, Kenya   
Principal Investigator(s)
1. Samuel Kariuki
Site(s) in Kenya
MMM MUKURU HEALTH CENTRE
 
16-07-2025 View

387.

ECCT/22/09/02   LISA Trial
    Levonorgestrel intrauterine system effects on hemoglobin and serum ferritin among anemic women in Kenya: An open label randomized trial to compare with an oral contraceptive regimen that provides supplemental ferrous fumarate tablets   
Principal Investigator(s)
1. Faith Mugure Thuita
Site(s) in Kenya
Kangemi Health Centre
 
23-02-2023 View

388.

ECCT/12/10/01   REMEMBER STUDY
    Reducing Early Mortality and Early Morbidity by Empiric Tuberculosis Treatment Regimens   
Principal Investigator(s)
1. Lucy N/A Koech
Site(s) in Kenya
1. KEMRI/WRP Kericho (Kericho county)
2. AMPATH Moi University Eldoret (Kericho county)
 
05-12-2012 View

389.

ECCT/25/08/07   ACCEDE Usability Study
    USABILITY, ACCEPTABILITY, FEASIBILITY AND COST OF CONTINUOUS GLUCOSE MONITORING BY PERSONS LIVING WITH TYPE 1 DIABETES MELLITUS, HEALTH CARE PROVIDERS AND CAREGIVERS AT THE PAEDIATRIC AND ADOLESCENT ENDOCRINOLOGY CLINIC IN KENYATTA NATIONAL HOSPITAL   
Principal Investigator(s)
1. Prisca Amolo
Site(s) in Kenya
Kenyatta National Hospital
 
10-12-2025 View

390.

ECCT/26/05/01   C1091009 Study site 1193
    Phase 3, Randomized, Placebo-Controlled, Double-Blinded Trial to Evaluate the Safety, Tolerability, and Immunogenicity of a Multivalent Group B Streptococcus Vaccine in Healthy Pregnant Women and Their Infants   
Principal Investigator(s)
1. Janet Nyawira Oyieko
Site(s) in Kenya
1. KEMRI Butere Clinical Research Centre (Kakamega county)
2. Kenya Medical Research Institute Walter Reed Project (Kericho county)
3. Kenya Medical Research Institute (KEMRI) - Centre for Global Health Research (Kisumu county)
4. Victoria Biomedical Research Institute Kisumu County Referral Hospital (Kisumu county)
 
08-11-2026 View